AbCellera Biologics Inc. ABCL Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.06B.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s market capitalization?
- AbCellera Biologics Inc. (ABCL) reported market capitalization of $1.06B in Q1 2026.
- How has AbCellera Biologics Inc.'s market capitalization changed year-over-year?
- AbCellera Biologics Inc.'s market capitalization increased by 59.2% year-over-year, from $664.51M to $1.06B.
- What is the long-term trend for AbCellera Biologics Inc.'s market capitalization?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s market capitalization has grown at a -38.2% compound annual growth rate (CAGR), from $11.33B to $1.02B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.